Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
2 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
3 | Adherens junction 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
4 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
5 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
6 | AMPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
7 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
8 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
9 | Autophagy - animal 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
10 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
11 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
12 | Breast cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
13 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
14 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
15 | EGFR tyrosine kinase inhibitor resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
16 | Endocrine resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
17 | Endocrine resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
18 | Endocrine resistance 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
19 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
20 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
21 | Endocytosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
22 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
23 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
24 | Focal adhesion 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
25 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
26 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
27 | FoxO signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
28 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
29 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
30 | Glioma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
31 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
32 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
33 | Hepatocellular carcinoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
34 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
35 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
36 | HIF-1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
37 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
38 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
39 | Long-term depression 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
40 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
41 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
42 | Longevity regulating pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
43 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
44 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
45 | Longevity regulating pathway - multiple species 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
46 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
47 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
48 | MAPK signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
49 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
50 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
51 | Melanoma 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
52 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
53 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
54 | mTOR signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
55 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
56 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
57 | Oocyte meiosis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
58 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
59 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
60 | Ovarian steroidogenesis 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
61 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
62 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
63 | Pathways in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
64 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
65 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
66 | PI3K-Akt signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
67 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
68 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
69 | Progesterone-mediated oocyte maturation 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
70 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
71 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
72 | Prostate cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
73 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
74 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
75 | Proteoglycans in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
76 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
77 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
78 | Rap1 signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
79 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
80 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
81 | Ras signaling pathway 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
82 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
83 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
84 | Signaling pathways regulating pluripotency of stem cells 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|
85 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Linsitinib Linsitinib 💬
| Linsitinib | 232 [1] 232 💬
|
86 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Mecasermin Mecasermin 💬
| Mecasermin | 065 [6] 65, 78, 96, 168, 265, 299 💬
|
87 | Transcriptional misregulation in cancer 💬 1 gene, 3 drugs (DrugBank) and 8 diseases |
IGF1R [1] IGF1R 💬
|
Teprotumumab Teprotumumab 💬
| Teprotumumab | 051 [1] 51 💬
|